Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-31

Clinical Trial Update: Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer

View source ↗

Summary

An update on clinical studies examining the role of the tumor suppressor PTEN in endometrial cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Endometrial Neoplasms | Status: COMPLETED